Mobile

News Massive Bio Has Onboarded Over 100,000 Cancer Patients To Find Their Clinical Trial

Tomorrow’s ROS1-Positive Cancer Treatment Today

Get ahead of standard treatment for ROS1-positive cancer with new-generation therapies. Access the latest treatments with clinical trial matching.

Start Your Journey

Compliant with

    Find Your Treatment Now

    A Patient Advocate will reach out to you soon.

    Your personal data is fully confidential and 100% secure

    You can receive a guidebook with information about genomic testing by filling out the form.

      Find Your Treatment Now

      A Patient Advocate will reach out to you soon.

      Your personal data is fully confidential and 100% secure

      You can receive a guidebook with information about genomic testing by filling out the form.

      Understanding ROS1-Positive Cancer

      ROS1 is a gene, which is a basic unit of heredity passed down from a parent to a child. In ROS1-positive cancer, the ROS1 gene fuses with another gene. This fusion causes ROS1 to become overactive, which results in uncontrolled growth of cells that can form cancerous tumors. ROS1 fusions are not inherited, but acquired during a person’s lifetime. Other terms you may see or hear to describe ROS1 fusions include ROS1 fusion positive, ROS1 rearrangements, and ROS1 gene mutations.  

      What Types of Cancer are Associated With ROS1 Fusions? 

      ROS1 fusions are found in about 1 to 2 percent of lung cancer cases, according to the American Lung Association (ALA). Specifically, this gene fusion commonly occurs in people with a form of the disease called adenocarcinoma non-small cell lung cancer. This type of lung cancer tends to be diagnosed in younger patients who do not have a history of heavy smoking, according to the ALA.  

      Several other cancers are linked to ROS1 fusions, including the following: 

      • ROS1-positive breast cancer (invasive ductal carcinoma) 
      • ROS1-positive glioblastoma 
      • ROS1-positive colorectal cancer 
      • ROS1-positive ovarian cancer 

       

      Treatment of ROS1-Positive Cancer: What Are the Options? 

      The treatment your doctor will prescribe for ROS1-positive cancer will depend on a variety of factors, including which form of cancer you have, whether it has metastasized (or spread), and what treatment you have already received. Treatments for ROS1-positive cancers include: 

      • Surgery: Surgical removal of cancerous tumors.  
      • Chemotherapy: A general term for drugs that kill cancer cells and prevent them from spreading. 
      • Radiation therapy: The use of high-energy beams to destroy cancer cells. 
      • Targeted therapy: Medications that block or inhibit molecules that cause cancer to grow and spread. 
      • Immunotherapy: Medications that stimulate the body’s natural defense network, the immune system, to find and destroy cancer cells. 
      • Clinical trials: Standard treatments don’t work for all patients with ROS1-positive cancer; in other patients, the benefits of these treatments can diminish over time. In these cases, doctors often recommend enrolling in a clinical trial, which is a type of scientific study in which researchers evaluate a new medical therapy.  
      Why Massive Bio?
      Our AI matching tool makes cancer treatment simple.

      We combine the power of technology with our dedicated team of medical providers to find you the best treatment options available.

      Access the free matching tool

      Having cancer is hard enough. Treatment should be easy.

      Massive Bio specializes in finding clinical trials of new treatments for ROS1-positive cancers and other cancers linked to gene fusions or mutations. Patients who choose to enroll in clinical trials can receive cutting-edge treatment and high-quality care under the direction of doctors, nurses, and other healthcare professionals who are participating in research to discover new therapies for cancer. Patients can gain access to promising drugs and innovative treatments long before they’re made available to the public. If you’ve been diagnosed with ROS1-positive cancer, we’re here to help. If you aren’t sure if you have ROS1-positive cancer, that’s okay. Additional testing can help you determine your exact diagnosis. 

      • Team-based care: Have a team of doctors and nurses fighting cancer with you every step of the way.
      • Transportation solutions: We provide transportation to ensure you get the treatment you need.
      • Affordable care: All treatment and clinical care are free when you participate in trials.
      • VIP treatment: Receive world-class treatment and access quality resources to help you maximize treatment outcomes.
      Hear from our Co founder & CEO

      Selin Kurnaz on how she struggled to find the right treatment for her uncle and started Massive Bio to help others.

      There is a major gap between what pharmaceutical companies are working on right now vs. what cancer patients are getting. Massive Bio is revolutionizing this process.
      Selin Kurnaz, Co-Founder, CEO
      People's stories
      Star Star Star Star Star

      “Massive Bio has gone above and beyond to connect my family with the right care during Covid-19. I really appreciate their staff’s consistent and clear outreach during this process.“

      Mylan Tran
      Cancer Patient Caregiver
      Google Reviews
      You are in good hands

      Talk to us. Our nurses and patient advocates are here and happy to help you. You are not alone in this fight.

      Call +1 844 627 7246
      Cancer Clinical Trials Patients Cancer Clinical Trials Patients

      What is a HER2-Positive Cancer clinical trial?

      Clinical trials test the latest scientific advancements in HER2-Positive cancer treatment. Patients who choose to enroll in trials can receive cutting-edge treatment and high-quality care under the direction of scientists, doctors, and researchers. HER2-Positive cancer patients can gain access to promising drugs and innovative treatments long before they're made available to the public.

      Cancer Ribbon
      About Massive Bio

      Cancer is an unfortunate reality that touches most of us at some point in our lives. If you or a loved one has cancer, you may have heard or read that clinical trials could offer access to innovative new treatments. But what exactly is a clinical trial? In this video, Massive Bio co-founder Arturo Loaiza-Bonilla, MD, explains how clinical trials work, what to expect if you enroll in one, and why a clinical trial can be an important treatment option for many cancer patients.

       

      We dream of the day when cancer disappears from our lives. Massive Bio is working tirelessly on achieving that goal.